TEKMIRA PHARM
TEKMIRA PHARM operates in Diversified Metals & Mining.
Market Cap & Net Worth: TEKMIRA PHARM (I9DN)
TEKMIRA PHARM (BE:I9DN) has a market capitalization of $39.34K (€38.33K) as of March 19, 2026. Listed on the BE stock exchange, this Germany-based company holds position #42767 globally and #6751 in its home market, demonstrating a 1.77% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying TEKMIRA PHARM's stock price €3.92 by its total outstanding shares 9782 (9.78K).
TEKMIRA PHARM Market Cap History: 2015 to 2025
TEKMIRA PHARM's market capitalization history from 2015 to 2025. Data shows change from $40.94K to $39.34K (-3.40% CAGR).
TEKMIRA PHARM Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how TEKMIRA PHARM's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
TEKMIRA PHARM's market cap is 0.00 times its annual revenue
0.01x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $22.74K | $1.49 Million | -$384.16 Million | 0.02x | N/A |
| 2017 | $40.39K | $10.70 Million | -$84.41 Million | 0.00x | N/A |
| 2018 | $31.53K | $5.95 Million | -$57.06 Million | 0.01x | N/A |
| 2019 | $21.69K | $6.01 Million | -$153.72 Million | 0.00x | N/A |
| 2020 | $27.62K | $6.91 Million | -$63.74 Million | 0.00x | N/A |
| 2021 | $32.57K | $10.99 Million | -$76.25 Million | 0.00x | N/A |
| 2022 | $21.31K | $39.02 Million | -$69.46 Million | 0.00x | N/A |
| 2023 | $22.64K | $18.14 Million | -$72.85 Million | 0.00x | N/A |
Competitor Companies of I9DN by Market Capitalization
Companies near TEKMIRA PHARM in the global market cap rankings as of March 19, 2026.
Key companies related to TEKMIRA PHARM by market ranking:
- BERKSHIRE HATH-A (BE:BRH): Ranked #2328 globally with a market cap of $6.43 Billion USD ( €6.27 Billion EUR).
- BERKSHIRE HATH-A - Dusseldorf Stock Exchang (DU:BRH): Ranked #2395 globally with a market cap of $6.17 Billion USD ( €6.02 Billion EUR).
- Itissalat Al-Maghrib (IAM) S.A (PINK:MAOTF): Ranked #3760 globally with a market cap of $3.25 Billion USD.
- NET ONE SYSTEMS (MU:NOX): Ranked #4660 globally with a market cap of $2.24 Billion USD ( €2.18 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #2328 | BERKSHIRE HATH-A | BE:BRH | $6.43 Billion | €634500.00 |
| #2395 | BERKSHIRE HATH-A - Dusseldorf Stock Exchang | DU:BRH | $6.17 Billion | €638000.00 |
| #3760 | Itissalat Al-Maghrib (IAM) S.A | PINK:MAOTF | $3.25 Billion | $14.80 |
| #4660 | NET ONE SYSTEMS | MU:NOX | $2.24 Billion | €1000000.00 |
TEKMIRA PHARM Historical Marketcap From 2015 to 2025
Between 2015 and today, TEKMIRA PHARM's market cap moved from $40.94K to $ 39.34K, with a yearly change of -3.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €39.34K | +30.34% |
| 2024 | €30.18K | +33.30% |
| 2023 | €22.64K | +6.24% |
| 2022 | €21.31K | -34.57% |
| 2021 | €32.57K | +17.92% |
| 2020 | €27.62K | +27.36% |
| 2019 | €21.69K | -31.21% |
| 2018 | €31.53K | -21.95% |
| 2017 | €40.39K | +77.62% |
| 2016 | €22.74K | -44.44% |
| 2015 | €40.94K | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of TEKMIRA PHARM was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $39.34K USD |
| MoneyControl | $39.34K USD |
| MarketWatch | $39.34K USD |
| marketcap.company | $39.34K USD |
| Reuters | $39.34K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.